Literature DB >> 22140377

Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications.

J Wincent1, D L Bruno, B W M van Bon, A Bremer, H Stewart, E M H F Bongers, C W Ockeloen, M H Willemsen, D D A Keays, G Baird, D F Newbury, T Kleefstra, C Marcelis, U Kini, Z Stark, R Savarirayan, L J Sheffield, O Zuffardi, H R Slater, B B de Vries, S J L Knight, B-M Anderlid, J Schoumans.   

Abstract

The chromosome region 22q11.2 has long been recognized to be susceptible to genomic rearrangement. More recently, this genomic instability has been shown to extend distally (involving LCR22E-H) to the commonly deleted/duplicated region. To date, 21 index cases with 'distal' 22q11.2 duplications have been reported. We report on the clinical and molecular characterization of 16 individuals with distal 22q11.2 duplications identified by DNA microarray analysis. Two of the individuals have been partly described previously. The clinical phenotype varied among the patients in this study, although the majority displayed various degrees of developmental delay and speech disturbances. Other clinical features included behavioral problems, hypotonia, and dysmorphic facial features. Notably, none of the patients was diagnosed with a congenital heart defect. We found a high degree of inherited duplications. Additional copy number changes of unclear clinical significance were identified in 5 of our patients, and it is possible that these may contribute to the phenotypic expression in these patients as has been suggested recently in a 2-hit 'digenic' model for 16p12.1 deletions. The varied phenotypic expression and incomplete penetrance observed for distal 22q11.2 duplications makes it exceedingly difficult to ascribe pathogenicity for these duplications. Given the observed enrichment of the duplication in patient samples versus healthy controls, it is likely that distal 22q11.2 duplications represent a susceptibility/risk locus for speech and mild developmental delay.

Entities:  

Year:  2011        PMID: 22140377      PMCID: PMC3214948          DOI: 10.1159/000327982

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  52 in total

1.  A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects.

Authors:  S C Saitta; J M McGrath; H Mensch; T H Shaikh; E H Zackai; B S Emanuel
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features.

Authors:  A Alberti; C Romano; M Falco; F Calì; P Schinocca; O Galesi; A Spalletta; D Di Benedetto; M Fichera
Journal:  Clin Genet       Date:  2007-02       Impact factor: 4.438

3.  Distal 22q11.2 microduplication encompassing the BCR gene.

Authors:  Maria Descartes; Judy Franklin; Teresita Diaz de Ståhl; Arkadiusz Piotrowski; Carl E G Bruder; Jan P Dumanski; Andrew J Carroll; Fady M Mikhail
Journal:  Am J Med Genet A       Date:  2008-12-01       Impact factor: 2.802

Review 4.  Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature.

Authors:  J Leana-Cox; S Pangkanon; K R Eanet; M S Curtin; E A Wulfsberg
Journal:  Am J Med Genet       Date:  1996-11-11

5.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome.

Authors:  L Edelmann; R K Pandita; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

6.  Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome.

Authors:  R Matsuoka; M Kimura; P J Scambler; B E Morrow; S Imamura; S Minoshima; N Shimizu; H Yamagishi; K Joh-o; S Watanabe; K Oyama; T Saji; M Ando; A Takao; K Momma
Journal:  Hum Genet       Date:  1998-07       Impact factor: 4.132

Review 7.  The 22q11.2 deletion syndrome.

Authors:  Hiroyuki Yamagishi
Journal:  Keio J Med       Date:  2002-06

8.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.

Authors:  B Morrow; R Goldberg; C Carlson; R Das Gupta; H Sirotkin; J Collins; I Dunham; H O'Donnell; P Scambler; R Shprintzen
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

9.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

10.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  12 in total

1.  22q11.2 Microduplication: An Enigmatic Genetic Disorder.

Authors:  Ranjit I Kylat
Journal:  J Pediatr Genet       Date:  2018-05-18

2.  Cross-sectional and longitudinal findings in patients with proximal 22q11.2 duplication: A retrospective chart study.

Authors:  Jente Verbesselt; Inge Zink; Jeroen Breckpot; Ann Swillen
Journal:  Am J Med Genet A       Date:  2021-09-07       Impact factor: 2.802

3.  A modified multiplex ligation-dependent probe amplification method for the detection of 22q11.2 copy number variations in patients with congenital heart disease.

Authors:  Xiaoqing Zhang; Yuejuan Xu; Deyuan Liu; Juan Geng; Sun Chen; Zhengwen Jiang; Qihua Fu; Kun Sun
Journal:  BMC Genomics       Date:  2015-05-08       Impact factor: 3.969

4.  Mouse Models of 22q11.2-Associated Autism Spectrum Disorder.

Authors:  Noboru Hiroi; Takeshi Hiramoto; Kathryn M Harper; Go Suzuki; Shuken Boku
Journal:  Autism Open Access       Date:  2012

5.  Distal 22q11.2 Microduplication: Case Report and Review of the Literature.

Authors:  Elana Pinchefsky; Laurence Laneuville; Myriam Srour
Journal:  Child Neurol Open       Date:  2017-11-01

6.  Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance.

Authors:  Karen J Woodward; Julie Stampalia; Hannah Vanyai; Hashika Rijhumal; Kim Potts; Fiona Taylor; Joanne Peverall; Tanya Grumball; Soruba Sivamoorthy; Hamid Alinejad-Rokny; John Wray; Andrew Whitehouse; Lakshmi Nagarajan; Jacqueline Scurlock; Sabine Afchani; Matthew Edwards; Ashleigh Murch; John Beilby; Gareth Baynam; Cathy Kiraly-Borri; Fiona McKenzie; Julian I T Heng
Journal:  Mol Genet Genomic Med       Date:  2019-01-04       Impact factor: 2.183

7.  Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder.

Authors:  Dianne F Newbury; Francesca Mari; Elham Sadighi Akha; Kay D Macdermot; Roberto Canitano; Anthony P Monaco; Jenny C Taylor; Alessandra Renieri; Simon E Fisher; Samantha J L Knight
Journal:  Eur J Hum Genet       Date:  2012-08-22       Impact factor: 4.246

8.  Behavioral abnormalities are common and severe in patients with distal 22q11.2 microdeletions and microduplications.

Authors:  Valerie Lindgren; Anne McRae; Richard Dineen; Alexandria Saulsberry; George Hoganson; Michael Schrift
Journal:  Mol Genet Genomic Med       Date:  2015-04-16       Impact factor: 2.183

9.  Identification of Proximal and Distal 22q11.2 Microduplications among Patients with Cleft Lip and/or Palate: A Novel Inherited Atypical 0.6 Mb Duplication.

Authors:  Maryam Sedghi; Hossein Abdali; Mehrdad Memarzadeh; Mansoor Salehi; Narges Nouri; Majid Hosseinzadeh; Nayereh Nouri
Journal:  Genet Res Int       Date:  2015-11-12

10.  Homozygous microdeletion of exon 5 in ZNF277 in a girl with specific language impairment.

Authors:  Fabiola Ceroni; Nuala H Simpson; Clyde Francks; Gillian Baird; Gina Conti-Ramsden; Ann Clark; Patrick F Bolton; Elizabeth R Hennessy; Peter Donnelly; David R Bentley; Hilary Martin; Jeremy Parr; Alistair T Pagnamenta; Elena Maestrini; Elena Bacchelli; Simon E Fisher; Dianne F Newbury
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.